Close

Product Liability Lawyer Blog

Updated:

Takeda Sanctioned for Misconduct in Actos Litigation

Takeda Pharmaceuticals is facing pending legal action in a multidistrict litigation because the company’s drug, Actos, significantly increases the risk of patients developing bladder cancer. Plaintiffs have been successful in past cases in taking legal action against the pharmaceutical company, with one jury awarding $9 million in damages. However, some…

Updated:

Removal of Vaginal Mesh Can Have Long-Term Consequences

Vaginal mesh has been clearly demonstrated to cause serious side effects for many patients. Unfortunately, mesh products can cause significant pain, especially during intercourse. Vaginal mesh can also result in organ perforation, infection, mesh erosion and recurrent pelvic organ prolapse (POP) among the other serious symptoms and complications. At the…

Updated:

Older Stryker Pain Pump Lawsuit Will Not Proceed, Eighth Circuit Rules

The U.S. Court of Appeals for the Eighth Circuit has effectively dismissed plaintiff efforts to seek damages against a medical pain pump device implanted post-surgery, finding there was no way at the time of the procedure the manufacturer could have recognized the device’s potential risk. The case of Mack, et…

Updated:

Teague, et al v. Johnson & Johnson, et al – TVM Defendant Motion to Transfer Mass Tort Back to Federal Court Denied

Defendants in a mass tort involving some 702 women claiming harm from transvaginal mesh medical devices were denied a request to have the case moved back to federal court, where they perceive an advantage. In theory, Boston transvaginal mesh lawyers know that both sides should be able to receive a…

Updated:

Consumer Group Seeks Investigation into “Reckless” Johnson & Johnson

A nonprofit consumer advocacy group has requested that the U.S. Senate launch an investigation into Johnson & Johnson. The group alleges a pattern of “reckless” conduct. The same consumer group, the Corporate Action Network, has also urged the Department of Justice to look into whether Johnson & Johnson knowingly destroyed…

Updated:

Stryker Prepares for Thousands of Pending Cases

Stryker has set aside $133 million in order to defend or settle cases arising from defective hip implant products. Problem products include the Stryker Rejuvenate and the Stryker ABG II. Both products contain metal components, although they are not traditional metal-on-metal hip implant systems. Unlike most hip replacement products, which…

Contact Us